Molecular mechanisms of PTEN in atherosclerosis: A comprehensive review

Atherosclerosis is a chronic inflammatory disease of the arterial wall caused by an imbalance of lipid metabolism and a maladaptive inflammatory response. A variety of harmful cellular changes associated with atherosclerosis include endothelial dysfunction, the migration of circulating inflammatory...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 2024-09, Vol.979, p.176857, Article 176857
Main Authors: Tian, Yuan, Liu, Yi-Fan, Wang, Yan-Yue, Li, Yong-Zhen, Ding, Wen-Yan, Zhang, Chi
Format: Article
Language:English
Subjects:
Apoptosis
Atherosclerosis
Autophagy
Inflammatory
Proliferation
PTEN
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atherosclerosis is a chronic inflammatory disease of the arterial wall caused by an imbalance of lipid metabolism and a maladaptive inflammatory response. A variety of harmful cellular changes associated with atherosclerosis include endothelial dysfunction, the migration of circulating inflammatory cells to the arterial wall, the production of proinflammatory cytokines, lipid buildup in the intima, local inflammatory responses in blood vessels, atherosclerosis-associated apoptosis, and autophagy. PTEN inhibits the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT)/mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity. Previous studies have shown that PTEN is closely related to atherosclerosis. This article reviews the role of PTEN in atherosclerosis from the perspectives of autophagy, apoptosis, inflammation, proliferation, and angiogenesis. [Display omitted]
ISSN:0014-2999
1879-0712
1879-0712
DOI:10.1016/j.ejphar.2024.176857